Exparel and Education to Avoid Opioids After Carpal Tunnel Release
Kettering Health Network
Summary
This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.
Description
As has become apparent in the media, as well as in the clinical practice of nearly every type of medicine over the last few years, the nation is currently experiencing an opioid epidemic. This is a significant public health issue that has sweeping consequences that reach far beyond the medical field. The investigators believe over the last several decades, public perception regarding pain, especially post-operatively, has changed for the worse. The nation is in need of a paradigm shift in the way pain is managed, and the way the public perceives this issue, especially regarding pain expectatio…
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * carpal tunnel syndrome diagnosed either by physical exam or EMG * age \>18. Exclusion Criteria: * allergy to bupivacaine * pre-operative opioid usage within the last six months * patients allergic to Percocet or acetaminophen * patients taking tricyclic antidepressants (interaction with bupivacaine) * vulnerable populations (prisoners or pregnant women)
Interventions
- DrugDiffering pain management strategy
The investigators aim to investigate an alternative (vs "standard") pain management strategy for post operative carpal tunnel release. All drugs used are FDA approved for these indications, and no drug itself is being investigated.
Locations (2)
- Orthopedic Associates of Southwest OhioDayton, Ohio
- Orthopedic Associates of Southwest OhioDayton, Ohio